nach oben

Maternal and Child Health Journal

Erschienen in:

01.08.2015

Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study

verfasst von: Karen A. McQueen, Jodie Murphy-Oikonen, Lindsay Desaulniers

Erschienen in: Maternal and Child Health Journal | Ausgabe 8/2015

Einloggen, um Zugang zu erhalten

Abstract

Neonatal Abstinence Syndrome (NAS) is one of the primary negative effects of substance use during pregnancy. The exact statistics regarding NAS and substance use during pregnancy are difficult to determine due to underreporting, especially in the context of pregnancy. Similarly, little is known regarding whether the severity of NAS differs based on substance exposure. The purpose of this study was to evaluate the prevalence of NAS and types of substance use during pregnancy, and determine whether the presentation of NAS symptoms differ based on the type of substance. A retrospective chart review was conducted over a one year period at a tertiary care hospital. One hundred thirty-one mother-infant pairs met the inclusion criteria of documented NAS scores using the Modified Finnegan Scoring Tool and substance use during pregnancy. The results identified a high prevalence of NAS (8.7 %) primarily as a result of exposure to illicit opioids and/or to methadone as the treatment for opioid addiction. In addition, more than half the women on methadone maintenance treatment continued to use additional substances primarily opiates. Infants who were exposed to methadone experienced more severe NAS compared to infants not exposed to methadone including higher peak scores, prolonged NAS treatment, and length of stay. Given the severity of symptoms of the methadone exposed infants and the high rate of opioid use with methadone treatment, evidence-based interventions are required to decrease the negative effects of NAS.

Nur mit Berechtigung zugänglich

Wendell, A. D. (2013). Overview and epidemiology of substance abuse in pregnancy. Clinical Obstetrics and Gynecology, 56(1), 91–96.PubMedCrossRef

Maguire, D., Cline, G. J., Parnell, L., & Tai, C. Y. (2013). Validation of the Finnegan Neonatal Abstinence Syndrome Tool-Short Form. Advances in Neonatal Care, 13(6), 430–437.PubMedCrossRef

Public Health Agency of Canada. (2009). What mother’s say: The Canadian maternity experiences survey. Ottawa, ON: PHAC.

Dow, K., Ordean, A., Murphy-Oikonen, J., Pereira, J., Koren, G., Roukema, H., et al. (2012). Neonatal abstinence syndrome clinical practice guidelines for Ontario. Journal of Population Therapeutics and Clinical Pharmacology, 19(3), e488–e506.PubMed

Hudak, M. L., & Tan, R. C. (2012). Committee on Drugs, Committee on Fetus and Newborn, American Academy of Pediatrics. Neonatal Drug Withdrawal Pediatrics, 129(2), e540–e560.

Hurd, Y. L., Wang, X., Anderson, V., Beck, O., Minkoff, H., & Dow-Edwards, D. (2005). Marijuana impairs growth in mid-gestation fetuses. Neurotoxicology and Teratology, 27(2), 221–229.PubMedCrossRef

Vucinovic, M., Roje, D., Vucinovic, Z., Capkun, V., Bucat, M., & Banovic, I. (2008). Maternal and neonatal effects of substance abuse during pregnancy: Our ten-year experience. Yonsei Medical Journal, 49(5), 705–713.PubMedCentralPubMedCrossRef

Finnegan, L. P., Connaughton, J. F, Jr, Kron, R. E., & Emich, J. P. (1975). Neonatal abstinence syndrome: Assessment and management. Addictive Diseases, 2(1–2), 141–158.PubMed

Barthell, J. E., & Mrozek, J. D. (2013). Neonatal drug withdrawal. Minnesota Medicine, 96(3), 48–50.PubMed

10.

Jansson, L. M., Velez, M., & Harrow, C. (2009). The opioid-exposed newborn: Assessment and pharmacologic management. Journal of Opioid Management, 5(1), 47–55.PubMedCentralPubMed

11.

Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., et al. (2010). Neonatal abstinence syndrome after methadone or buprenorphine exposure. New England Journal of Medicine, 363(24), 2320–2331.PubMedCentralPubMedCrossRef

12.

Lim, S., Prasad, M. R., Samuels, P., Gardner, D. K., & Cordero, L. (2009). High-dose methadone in pregnant women and its effect on duration of neonatal abstinence syndrome. American Journal of Obstetrics and Gynecology, 200(1), 70e1–70e5.CrossRef

13.

Keegan, J., Parva, M., Finnegan, M., Gerson, A., & Belden, M. (2010). Addiction in pregnancy. Journal of Addictive Diseases, 29(2), 175–191.PubMedCrossRef

14.

O’Grady, M. J., Hopewell, J., & White, M. J. (2009). Management of neonatal abstinence syndrome: A national survey and review of practice. Archives of Disease in Childhood-Fetal and Neonatal Edition, 94(4), F249–F252.PubMedCrossRef

15.

Wong, S., Ordean, A., & Kahan, M. (2011). Society of obstetricians and gynecologists of Canada. SOGC clinical practice guidelines: Substance use in pregnancy: No. 256, April 2011. International Journal of Gynaecology and Obstetrics, 114(2), 190–202.PubMedCrossRef

16.

McQueen, K. A., Murphy-Oikonen, J., Gerlach, K., & Montelpare, W. (2011). The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants. Advances in Neonatal Care, 11(4), 282–290.PubMedCrossRef

17.

Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., Krans, E. E., McAllister, J. M., & Davis, M. M. (2012). Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. JAMA, 307(18), 1934–1940.PubMedCrossRef

18.

Burns, L., & Mattick, R. P. (2007). Using population data to examine the prevalence and correlates of neonatal abstinence syndrome. Drug and Alcohol Review, 26(5), 487–492.PubMedCrossRef

19.

Greene, C. M., & Goodman, M. H. (2003). Neonatal abstinence syndrome: Strategies for care of the drug-exposed infant. Neonatal Network, 22(4), 15–25.PubMedCrossRef

20.

Fischer, B., Jones, W., & Rehm, J. (2014). Trends and changes in prescription opioid analgesic dispensing in Canada 2005–2012: An update with a focus on recent interventions. BMC Health Services Research, 14, 90. doi:10.1186/1472-6963-14-90.

21.

Glatstein, M. M., Garcia-Bournissen, F., Finkelstein, Y., & Koren, G. (2008). Methadone exposure during lactation. Canadian Family Physician, 54(12), 1689–1690.PubMedCentralPubMed

22.

Konijnenberg, C., & Melinder, A. (2011). Prenatal exposure to methadone and buprenorphine: A review of the potential effects on cognitive development. Child Neuropsychol, 17(5), 495–519.PubMedCrossRef

23.

Finnegan, L. P. (2000). Women, pregnancy and methadone. Heroin Addiction and Related Clinical Problems, 2(1), 1–8.

24.

Marcellus, L. (2002). Care of substance-exposed infants: The current state of practice in Canadian hospitals. The Journal of Perinatal and Neonatal Nursing, 16(3), 51–68.PubMedCrossRef

25.

Bolnick, J. M., & Rayburn, W. F. (2003). Substance use disorders in women: Special considerations during pregnancy. Obstetrics and Gynecology Clinics of North America, 30(3), 545–558.PubMedCrossRef

26.

Cleary, B. J., Donnelly, J., Strawbridge, J., Gallagher, P. J., Fahey, T., Clarke, M., et al. (2010). Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis. Addiction, 105(12), 2071–2084.PubMedCrossRef

27.

Mattick RP, Breen C, Kimber J, Davoli M. (2009) Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev(3):CD002209.

28.

Pritham, U. A., Paul, J. A., & Hayes, M. J. (2012). Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 41(2), 180–190.PubMedCentralPubMedCrossRef

29.

Finnegan, L. (2013). Substance abuse in Canada: Licit and illicit drug use during pregnancy: Maternal, neonatal and early childhood consequences. Ottawa: Canadian Centre on Substance Abuse.

30.

Ordean, A., Kahan, M., Graves, L., Abrahams, R., & Boyajian, T. (2013). Integrated care for pregnant women on methadone maintenance treatment: Canadian primary care cohort study. Canadian Family Physician, 59(10), e462–e469.PubMedCentralPubMed

31.

Goff, M., & O’Connor, M. (2007). Perinatal care of women maintained on methadone. Journal Midwifery Womens Health, 52(3), e23–e26.CrossRef

32.

Schilling, R., Dornig, K., & Lungren, L. (2006). Treatment of heroin dependence: Effectiveness, costs, and benefits of methadone maintenance. Research on Social Work Practice, 16(1), 48–56.CrossRef

33.

Ward, J., Hall, W., & Mattick, R. P. (1999). Role of maintenance treatment in opioid dependence. Lancet, 353(9148), 221–226.PubMedCrossRef

34.

Abdel-Latif, M. E., Pinner, J., Clews, S., Cooke, F., Lui, K., & Oei, J. (2006). Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics, 117(6), e1163–e1169.PubMedCrossRef

35.

Jansson, L. M., Choo, R., Velez, M. L., Harrow, C., Schroeder, J. R., Shakleya, D. M., et al. (2008). Methadone maintenance and breastfeeding in the neonatal period. Pediatrics, 121(1), 106–114.PubMedCrossRef

36.

Dryden, C., Young, D., Hepburn, M., & Mactier, H. (2009). Maternal methadone use in pregnancy: Factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG, 116(5), 665–671.PubMedCrossRef

37.

Jansson, L. M., Velez, M. L., & Harrow, C. (2004). Methadone maintenance and lactation: A review of the literature and current management guidelines. Journal of Human Lactation, 20(1), 62–71.PubMedCrossRef

38.

Jones, H. E., Finnegan, L. P., & Kaltenbach, K. (2012). Methadone and buprenorphine for the management of opioid dependence in pregnancy. Drugs, 72(6), 747–757.PubMedCrossRef

39.

Lacroix, I., Berrebi, A., Garipuy, D., Schmitt, L., Hammou, Y., Chaumerliac, C., et al. (2011). Buprenorphine versus methadone in pregnant opioid-dependent women: A prospective multicenter study. European Journal of Clinical Pharmacology, 67(10), 1053–1059.PubMedCrossRef

40.

Unger, A., Jagsch, R., Jones, H., Arria, A., Leitich, H., Rohrmeister, K., et al. (2011). Randomized controlled trials in pregnancy: Scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison. Addiction, 106(7), 1355–1362.PubMedCentralPubMedCrossRef

41.

Gaalema, D. E., Scott, T. L., Heil, S. H., Coyle, M. G., Kaltenbach, K., Badger, G. J., et al. (2012). Differences in the profile of neonatal abstinence syndrome signs in methadone-versus buprenorphine-exposed neonates. Addiction, 107(Suppl 1), 53–62.PubMedCentralPubMedCrossRef

42.

Murphy-Oikonen, J., Montelpare, W. J., Southon, S., Bertoldo, L., & Persichino, N. (2010). Identifying infants at risk for neonatal abstinence syndrome: A retrospective cohort comparison study of 3 screening approaches. The Journal of Perinatal and Neonatal Nursing, 24(4), 366–372.PubMedCrossRef

Titel: Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study
verfasst von: Karen A. McQueen
Jodie Murphy-Oikonen
Lindsay Desaulniers
Publikationsdatum: 01.08.2015
Verlag: Springer US
Erschienen in: Maternal and Child Health Journal / Ausgabe 8/2015
Print ISSN: 1092-7875
Elektronische ISSN: 1573-6628
DOI: https://doi.org/10.1007/s10995-015-1689-y

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study

Abstract

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2015

The Effect of Early Marriages and Early Childbearing on Women’s Nutritional Status in India

Associations Between Orphan and Vulnerable Child Caregiving, Household Wealth Disparities, and Women’s Overweight Status in Three Southern African Countries Participating in Demographic Health Surveys

Racial/Ethnic Disparities in Inadequate Gestational Weight Gain Differ by Pre-pregnancy Weight

A Review of e-Health Interventions for Maternal and Child Health in Sub-Sahara Africa

Comparison of Food Intake Among Infants and Toddlers Participating in a South Central Texas WIC Program Reveals Some Improvements After WIC Package Changes

“We Know but We Don’t Really Know”: Diet, Physical Activity and Cardiovascular Disease Prevention Knowledge and Beliefs Among Underserved Pregnant Women